Tracking CRVS? Get live short interest, options flow, and signals on ORTEX.Sign up free →

Corvus Pharmaceuticals, Inc. (CRVS) short interest & options flow

NASDAQ

Corvus Pharmaceuticals heads into its August 4 earnings report with nearly a quarter of its free float sold short — one of the more charged setups in small-cap biotech right now. Short sellers hold 23.9% of CRVS's free float, a level that has barely budged over the past month but has eased roughly 4.4% week-on-week as some bears trimmed positions. Days to cover is a lengthy 12.6…

$9.65+1.37% 1d-3.98% 1w-23.17% 1mClose: 19 Oct 2026

Short interest % of float: High
Cost to borrow: Low
Availability
Put / call ratio

Market cap: $812M
Next earnings: 3 Nov 2026

See the full picture on ORTEX →Live short interest, options flow, signals, 13F filings, and more.

Key data as of 20 Oct 2026

CRVS news and analysis

RSS

No long-form analysis yet for CRVS. Pulse alerts and the live data picture are available on ORTEX.

Open CRVS on ORTEX →

Want the live picture for CRVS?

Short interest updated daily, real-time options flow, analyst consensus deltas, 13F positioning, ORTEX Alpha signals, and every article ORTEX publishes for CRVS — free to start on ORTEX.